Random drug screens definition

Random drug screens means laboratory tests to detect the presence related to a substance use disorder in body fluids which are performed at irregular intervals not known in advance by the person being tested.
Sample 1Sample 2Sample 3
Random drug screens means laboratory tests to detect the presence of drugs of abuse in body fluids and other biologic specimens that are performed at irregular intervals not known in advance by the person to be tested.
Sample 1Sample 2Sample 3
Random drug screens means laboratory tests to de- tect the presence of drugs ((of abuse)) in body fluids and other bio- logic specimens that are performed at irregular intervals not known in advance by the person to be tested.
Sample 1Sample 2Sample 3

Examples of Random drug screens in a sentence

  • Random drug screens may be performed at any time during this program.

  • Random drug screens will be at least monthly during the first 18 months following discharge from inpatient treatment.

  • Random Drug Tests Random drug screens will be conducted for all safety sensitive employment positions, in accordance with the drug testing guidelines set forth by the Department of Transportation.

  • Random drug screens will be paid for by Central Catholic Jr/Sr High School.

  • Random drug screens may be required by Northwestern for the remainder of the student’s enrollment.

  • Random drug screens should also be a part of the FIS role in the field.

  • Random drug screens may be done at any time in the program.2. Met all clinical facility requirements including Federal OSHA and HIPAA standards.3. Completion of any facility requirements (i.e. computer or equipment orientation) by specified deadline.For continuing and returning students, the requirements cannot expire during an academic semester.

  • Random drug screens may be performed during the program.2. Will be required to sign a statement, before beginning the nursing program, that states they have read and understand ACA §17-87-312 and the specific offenses which, if pleaded guilty, nolo contender, or found guilty of will make an individual ineligible to receive or hold a license in Arkansas.

  • Random drug screens shall be conducted at least twice (2) per year.

  • Random drug screens will be performed periodically throughout the nursing program and as required by clinical facilities.6. An interview with a nursing applicant may be requested.


More Definitions of Random drug screens

Random drug screens means the collection of specified bodi- ly fluids together with laboratory tests to detect the presence of drugs related to a substance use. Collection must occur at irregular intervals not known in advance by the veterinarian.
Sample 1Sample 2
Random drug screens means the observed collection of
Sample 1
Random drug screens means the collection of specified bodi- ly fluids together with laboratory tests to detect the presence of
Sample 1
Random drug screens means to test an individual selected randomly for drug usage without notice to advance prison Facility safety and individual Inmate treatment.
Sample 1

Related to Random drug screens

  • Drug sample means a unit of a prescription drug that is not intended to be sold and is intended to promote the sale of the drug.

  • Analytical x-ray system means a group of components utilizing x-rays to determine the elemental composition or to examine the microstructure of materials.

  • Phase I Clinical Trial means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate information on product safety, tolerability, pharmacological activity or pharmacokinetics, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(a) or its foreign equivalents.

  • Diagnostic x-ray system means an x-ray system designed for irradiation of any part of the human or animal body for the purpose of diagnosis or visualization.

  • Automated drug dispensing system means a mechanical or electronic system that performs

  • Assay means a laboratory analysis of Crude Petroleum to include the following: A.P.I. Gravity, Reid vapor pressure, composition, pour point, water and sediment content, sulfur content, viscosity, distillation, hydrogen sulfide, flash/boiling point and other characteristics as may be required by Carrier.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Healing arts screening means the testing of human beings using x-ray machines for the detection or evaluation of health indications when such tests are not specifically and individually ordered by a licensed practitioner of the healing arts legally authorized to prescribe such x-ray tests for the purpose of diagnosis or treatment.

  • Bioassay means the determination of kinds, quantities or concentrations, and, in some cases, the locations of radioactive material in the human body, whether by direct measurement, in vivo counting, or by analysis and evaluation of materials excreted or removed from the human body. For purposes of these regulations, "radiobioassay" is an equivalent term.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • HIV means human immunodeficiency virus.

  • Health screening means the use of one or more diagnostic tools to test a person for the presence or precursors of a particular disease.

  • API means American Petroleum Institute.

  • Fluoroscopic imaging assembly means a subsystem in which X-ray photons produce a visual image. It includes the image receptor(s) such as the image intensifier and spot-film device, electrical interlocks, if any, and structural material providing linkage between the image receptor and diagnostic source assembly.

  • Phase 2 Clinical Trial means a human clinical trial, for which the primary endpoints include a determination of dose ranges or an indication of efficacy in patients being studied as described in 21 C.F.R. §312.21(b), or an equivalent clinical trial in a country in the Territory other than the United States.